Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Focus on myeloproliferative diseases and myelodysplastic syndromes.

× No keyword cloud information.

31 in total

1. Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivo.

Authors: Benjamin S Braun; Joehleen A Archard; Jessica A G Van Ziffle; David A Tuveson; Tyler E Jacks; Kevin Shannon
Journal: Blood Date: 2006-05-23 Impact factor: 22.113

2. Bedside to bench: interfering with leukemic stem cells.

Authors: Daniela S Krause; Richard A Van Etten
Journal: Nat Med Date: 2008-05 Impact factor: 53.440

3. Cancer: More than kin and less than kind.

Authors: Kevin Shannon; Mignon Loh
Journal: Nature Date: 2009-08-13 Impact factor: 49.962

4. K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells.

Authors: Margaret E M Van Meter; Ernesto Díaz-Flores; Joehleen A Archard; Emmanuelle Passegué; Jonathan M Irish; Nikesh Kotecha; Garry P Nolan; Kevin Shannon; Benjamin S Braun
Journal: Blood Date: 2006-12-27 Impact factor: 22.113

Review 5. Gain-of-function c-CBL mutations associated with uniparental disomy of 11q in myeloid neoplasms.

Authors: Seishi Ogawa; Masashi Sanada; Lee-Young Shih; Takahiro Suzuki; Makoto Otsu; Hiromitsu Nakauchi; H Philip Koeffler
Journal: Cell Cycle Date: 2010-03-15 Impact factor: 4.534

6. Establishment of a xenograft model of human myelodysplastic syndromes.

Authors: Yukari Muguruma; Hiromichi Matsushita; Takashi Yahata; Shizu Yumino; Yumiko Tanaka; Hayato Miyachi; Yoshiaki Ogawa; Hiroshi Kawada; Mamoru Ito; Kiyoshi Ando
Journal: Haematologica Date: 2010-12-29 Impact factor: 9.941

Review 7. Targeting oncogenic Ras signaling in hematologic malignancies.

Authors: Ashley F Ward; Benjamin S Braun; Kevin M Shannon
Journal: Blood Date: 2012-08-16 Impact factor: 22.113

8. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche.

Authors: Koen Schepers; Eric M Pietras; Damien Reynaud; Johanna Flach; Mikhail Binnewies; Trit Garg; Amy J Wagers; Edward C Hsiao; Emmanuelle Passegué
Journal: Cell Stem Cell Date: 2013-07-11 Impact factor: 24.633

9. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency.

Authors: Carl R Walkley; Gemma Haines Olsen; Sebastian Dworkin; Stewart A Fabb; Jeremy Swann; Grant A McArthur; Susan V Westmoreland; Pierre Chambon; David T Scadden; Louise E Purton
Journal: Cell Date: 2007-06-15 Impact factor: 41.582

10. Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.

Authors: Tiffany Chang; Kimberly Krisman; Emily Harding Theobald; Jin Xu; Jon Akutagawa; Jennifer O Lauchle; Scott Kogan; Benjamin S Braun; Kevin Shannon
Journal: J Clin Invest Date: 2012-12-10 Impact factor: 14.808